CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 9 No. 2
 

Scar-Free Breast Reconstruction: New Technique

February 1, 2000

NEW ORLEANS—A new technique for breast reconstruction, used after a new method of skin-sparing mastectomy, offers patients a scar-free result, according to the surgeon who developed the method, Gino Rigotti, MD, head of the Plastic Surgery Department, Verona General Hospital, Italy.

The reconstruction involves insertion of a semilunar-shaped expander followed by definitive implant with a purse-string skin closure, Dr. Rigotti said at the 68th Annual Scientific Meeting of the American Society of Plastic and Reconstructive Surgeons (now known as the American Society of Plastic Surgeons).

From the reconstructive surgeon’s point of view, skin-sparing mastectomy is a contradiction in terms. “Skin-sparing mastectomy is a surgical method that reduces scars in the breast area but still requires very invasive reconstructive techniques,” Dr. Rigotti said.

The most commonly used immediate reconstruction techniques after skin-sparing mastectomy—free and pedicle TRAM flaps or latissimus dorsi flap with implant—are highly invasive and can leave functional or esthetic complications in donor areas in these patients, he said.

To avoid disfiguring scars, Dr. Rigotti developed the new technique based on what he considers the simplest, least invasive reconstruction method available—expansion followed by definitive implant.

The modified reconstruction method uses a purse-string closure to the central portion of the surgical wound, reducing the length and appearance of the scar. Additionally, the expander is not the usual round or oval shape—it is semilunar, a shape, Dr. Rigotti said, that allows the physician to expand only the inferior pole and thus achieve a more desirable shape and position.

In the Verona experience of Dr. Rigotti and his colleague Alessandra Marchi, MD, the complication rate in patients undergoing this method of reconstruction has been low. The major complication rate (complications resulting in failure of the reconstruction) is 3%, and the minor complication rate (complications that did not compromise the reconstruction) is 9%. This low complication rate is due, he believes, to the absence of the retracting longitudinal scars normally present with use of the other methods.

The complication rate is higher in patients who underwent or will undergo radiation therapy. For such patients, autologous tissue procedures are probably a better choice, he said.

The Italian surgeons began using the technique in August 1997 and described their experience in 90 patients over a 26-month period. Of this group, 50 patients had mastectomy followed only by expander introduction, and 40 patients completed the surgical procedure with definitive implant and areola-nipple reconstruction.

Skin excision in these patients was 5 cm to 13 cm wide, and an axillary dissection was made en bloc with the mammary gland when necessary.

Patients with central or paracentral infiltrating cancer or with comedo-type simple or multifocal intraductal lesions received a round, central skin incision, which always included the skin overlying the lump. The only obvious scar left in these patients after reconstruction was the one surrounding the newly reconstructed nipple-areola.

Patients with infiltrating cancer of the peripheral quadrants received a drop-shaped incision, which included the nipple/areola complex and the skin over the lump. The purse-string closure in this group was applied to the central portion of the surgical wound, reducing the length of the residual scar and preventing scar involvement of the tumor-free quadrants.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy